Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

AIR (Arne) Maas; G Murray; H Henney; N Kassem; V Legrand; M Mangelus; JP Muizelaar; N Stocchetti; N Knoller

doi:10.1016/S1474-4422(05)70253-2

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

AIR (Arne) Maas
, G Murray
, H Henney
, N Kassem
, V Legrand
, M Mangelus
, JP Muizelaar
, N Stocchetti
, N Knoller

Neurosurgery

Research output: Contribution to journal › Article › Academic › peer-review

255 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	38-45
Number of pages	8
Journal	Lancet Neurology
Volume	5
Issue number	1
DOIs	https://doi.org/10.1016/S1474-4422(05)70253-2
Publication status	Published - 2006

Research programs

EMC OR-01-45-01

Access to Document

10.1016/S1474-4422(05)70253-2

http://hdl.handle.net/1765/59953

Cite this

@article{b74a6309c0d145de86c2fb04d06184a8,

title = "Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial",

author = "Maas, \{AIR (Arne)\} and G Murray and H Henney and N Kassem and V Legrand and M Mangelus and JP Muizelaar and N Stocchetti and N Knoller",

year = "2006",

doi = "10.1016/S1474-4422(05)70253-2",

language = "Undefined/Unknown",

volume = "5",

pages = "38--45",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "1",

}

TY - JOUR

T1 - Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

AU - Maas, AIR (Arne)

AU - Murray, G

AU - Henney, H

AU - Kassem, N

AU - Legrand, V

AU - Mangelus, M

AU - Muizelaar, JP

AU - Stocchetti, N

AU - Knoller, N

PY - 2006

Y1 - 2006

U2 - 10.1016/S1474-4422(05)70253-2

DO - 10.1016/S1474-4422(05)70253-2

M3 - Article

C2 - 16361021

SN - 1474-4422

VL - 5

SP - 38

EP - 45

JO - Lancet Neurology

JF - Lancet Neurology

IS - 1

ER -